G01N 2333/183
Flaviviridae
Official title: Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus) or border disease virus
G01N2333/183 (Flaviviridae) appears on 211 US grants and 378 published applications in this corpus.
Search patents in G01N- Granted patents
- 211
- Published applications
- 378
- Assignees
- 215
- Inventors
- 868
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 1 |
| 2002 | 0 | 1 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 2 |
| 2006 | 0 | 1 |
| 2007 | 1 | 1 |
| 2008 | 0 | 6 |
| 2009 | 0 | 6 |
| 2010 | 3 | 16 |
| 2011 | 4 | 15 |
| 2012 | 2 | 12 |
| 2013 | 7 | 12 |
| 2014 | 9 | 17 |
| 2015 | 13 | 27 |
| 2016 | 15 | 21 |
| 2017 | 17 | 30 |
| 2018 | 24 | 31 |
| 2019 | 25 | 33 |
| 2020 | 16 | 34 |
| 2021 | 19 | 31 |
| 2022 | 16 | 25 |
| 2023 | 12 | 12 |
| 2024 | 13 | 16 |
| 2025 | 4 | 17 |
| 2026 | 9 | 10 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Method for detecting virus using SSDNA functionalized sensor15 Sep 2026US 12,736,531 B2University of Central Florida Research Foundation, Inc.
- Zika/dengue vaccine and application thereof2 Jun 2026US 12,642,846 B2Institute of Microbiology, Chinese Academy of Sciences
- Methods for reducing electrode gap distances in electronic devices and resulting devices having nanometer electrode gaps via liquid phase molecular layer deposition technique2 Jun 2026US 12,644,858 B2University of Utah Research Foundation
- Antibodies which specifically bind to dengue virus serotype 4 (DENV4) non-structural protein 1 (NS1) and methods of use thereof to detect a DENV4 infection21 Apr 2026US 12,606,611 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Methods and compositions for the detection of host protein cleavage by group IV viral proteases21 Apr 2026US 12,607,633 B2The Government of the United States of America, as represented by the Secretary of the Navy
- Human antibodies targeting zika virus ns1, ns1 polypeptides and uses thereof10 Sep 2026US 2026/0266820 A1Icahn School of Medicine at Mount Sinai
- Anti-toh1 antibodies and methods of use thereof3 Sep 2026US 2026/0258116 A1The Cleveland Clinic Foundation
- Micro-balance biosensors to detect whole viruses6 Aug 2026US 2026/0227361 A1University of Utah Research Foundation
- Methods, systems, and arrays for tickborne pathogen and disease analysis9 Jul 2026US 2026/0194522 A1Vibrant Holdings, LLC
- A method for determining the infectivity of a virus18 Jun 2026US 2026/0167703 A1Takeda Vaccines, Inc.
Most cited
By later US patents
- 2′-branched nucleosides and Flaviviridae mutation59US 7,824,851 B2Idenix Pharmaceuticals, Inc. · 2010
- Arbovirus indicative birth defect risk test43US 9,857,372 B1Reliant Immune Diagnostics, Inc. · 2018
- 2′-branched nucleosides and Flaviviridae mutation32US 8,674,085 B2Idenix Pharmaceuticals, Inc. · 2014
- System and method for immediate health assessment response system23US 10,473,659 B2Reliant Immune Diagnostics, Inc. · 2019
- Hydrogel platform for aqueous two-phase concentration of a target to enhance its detection18US 11,327,075 B2The Regents of the University of California · 2022